Sahara International Petrochemical Company (TADAWUL:2310)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,585	18,041	24,760	24,687	30,541	12,658
Market Cap Growth	-32.37%	-27.13%	0.29%	-19.17%	141.28%	-3.89%
Enterprise Value	15,215	20,282	26,480	26,488	34,542	18,073
Last Close Price	18.74	24.25	31.97	30.13	34.43	13.37
PE Ratio	91.03	42.34	21.07	6.87	8.50	71.98
Forward PE	33.28	18.83	17.35	8.92	11.92	33.12
PS Ratio	1.88	2.56	3.25	2.41	3.15	2.38
PB Ratio	0.87	1.13	1.51	1.48	1.94	0.92
P/TBV Ratio	0.99	1.28	1.72	1.69	2.29	1.06
P/FCF Ratio	48.55	25.17	15.37	5.21	6.76	11.49
P/OCF Ratio	13.52	13.13	10.58	4.64	6.26	7.86
PEG Ratio	0.76	1.06	-	-	0.85	1.89
EV/Sales Ratio	2.10	2.87	3.48	2.58	3.57	3.40
EV/EBITDA Ratio	11.25	13.55	11.70	5.39	6.58	14.59
EV/EBIT Ratio	31.85	30.78	18.92	6.56	7.77	51.85
EV/FCF Ratio	54.37	28.30	16.44	5.60	7.65	16.40
Debt / Equity Ratio	0.14	0.14	0.17	0.21	0.35	0.54
Debt / EBITDA Ratio	1.71	1.50	1.20	0.70	1.05	6.06
Debt / FCF Ratio	7.83	3.15	1.69	0.73	1.23	6.84
Asset Turnover	0.34	0.33	0.34	0.43	0.40	0.22
Inventory Turnover	4.54	4.84	4.35	4.26	4.24	4.45
Quick Ratio	0.88	1.06	1.21	1.43	1.60	1.13
Current Ratio	1.35	1.67	1.69	1.99	2.02	1.44
Return on Equity (ROE)	1.21%	2.88%	8.18%	24.36%	27.12%	0.41%
Return on Assets (ROA)	1.17%	1.91%	3.84%	10.53%	11.53%	0.91%
Return on Capital (ROIC)	1.38%	2.20%	4.45%	12.17%	13.04%	1.00%
Return on Capital Employed (ROCE)	2.30%	3.50%	7.20%	19.40%	20.60%	1.70%
Earnings Yield	1.10%	2.36%	4.75%	14.56%	11.76%	1.39%
FCF Yield	2.06%	3.97%	6.50%	19.18%	14.79%	8.71%
Dividend Yield	5.42%	4.12%	6.26%	10.79%	6.54%	3.74%
Payout Ratio	485.74%	170.16%	123.43%	65.60%	45.55%	207.03%
Buyback Yield / Dilution	-	-	-	0.28%	-0.71%	-25.42%
Total Shareholder Return	5.58%	4.12%	6.26%	11.07%	5.83%	-21.69%

Updated Oct 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.